全文获取类型
收费全文 | 55381篇 |
免费 | 4639篇 |
国内免费 | 169篇 |
专业分类
耳鼻咽喉 | 437篇 |
儿科学 | 2200篇 |
妇产科学 | 1591篇 |
基础医学 | 7863篇 |
口腔科学 | 1239篇 |
临床医学 | 7293篇 |
内科学 | 10886篇 |
皮肤病学 | 965篇 |
神经病学 | 5320篇 |
特种医学 | 1365篇 |
外科学 | 5557篇 |
综合类 | 572篇 |
一般理论 | 72篇 |
预防医学 | 6137篇 |
眼科学 | 1009篇 |
药学 | 3102篇 |
2篇 | |
中国医学 | 85篇 |
肿瘤学 | 4494篇 |
出版年
2024年 | 45篇 |
2023年 | 451篇 |
2022年 | 547篇 |
2021年 | 1476篇 |
2020年 | 1078篇 |
2019年 | 1582篇 |
2018年 | 1775篇 |
2017年 | 1329篇 |
2016年 | 1515篇 |
2015年 | 1637篇 |
2014年 | 2109篇 |
2013年 | 2963篇 |
2012年 | 4189篇 |
2011年 | 4381篇 |
2010年 | 2444篇 |
2009年 | 2186篇 |
2008年 | 3589篇 |
2007年 | 3720篇 |
2006年 | 3639篇 |
2005年 | 3405篇 |
2004年 | 3262篇 |
2003年 | 2979篇 |
2002年 | 2628篇 |
2001年 | 663篇 |
2000年 | 516篇 |
1999年 | 517篇 |
1998年 | 592篇 |
1997年 | 458篇 |
1996年 | 402篇 |
1995年 | 379篇 |
1994年 | 316篇 |
1993年 | 306篇 |
1992年 | 294篇 |
1991年 | 256篇 |
1990年 | 242篇 |
1989年 | 206篇 |
1988年 | 190篇 |
1987年 | 155篇 |
1986年 | 154篇 |
1985年 | 152篇 |
1984年 | 141篇 |
1983年 | 138篇 |
1982年 | 154篇 |
1981年 | 153篇 |
1980年 | 126篇 |
1979年 | 85篇 |
1978年 | 83篇 |
1977年 | 73篇 |
1976年 | 60篇 |
1975年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
4.
Susan E. Hickman Alexia M. Torke Greg A. Sachs Rebecca L. Sudore Anne L. Myers Qing Tang Giorgos Bakoyannis Bernard J. Hammes 《Journal of pain and symptom management》2019,57(6):1143-1150.e5
ContextIt is especially important that patients are well informed when making high-stakes, preference-sensitive decisions like those on the Physician Orders for Life-Sustaining Treatment (POLST) form. However, there is currently no way to easily evaluate whether patients understand key concepts when making these important decisions.ObjectivesTo develop a POLST knowledge survey.MethodsExpert (n = 62) ratings of key POLST facts were used to select items for a POLST knowledge survey. The survey was administered to nursing facility residents (n = 97) and surrogate decision-makers (n = 112). A subset (n = 135) were re-administered the survey after a standardized advance care planning discussion to assess the scale's responsiveness to change.ResultsThe 19-item survey demonstrated adequate reliability (α = 0.72.). Residents' scores (x = 11.4, standard deviation 3.3) were significantly lower than surrogate scores (x = 14.7, standard deviation 2.5) (P < 0.001). Scores for both groups increased significantly after administration of a standardized advance care planning discussion (P < 0.001). Although being a surrogate, age, race, education, cognitive functioning, and health literacy were significantly associated with higher POLST Knowledge Survey scores in univariate analyses, only being a surrogate (P < 0.001) and being white (P = 0.028) remained significantly associated with higher scores in multivariate analyses.ConclusionThe 19-item POLST Knowledge Survey demonstrated adequate reliability and responsiveness to change. Findings suggest the survey could be used to identify knowledge deficits and provide targeted education to ensure adequate understanding of key clinical decisions when completing POLST. 相似文献
5.
6.
7.
8.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
9.
10.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 下载免费PDF全文